201 related articles for article (PubMed ID: 8478073)
1. Characterization of kinetics and target proteins for binding of human complement component C3 to the surface-exposed outer membrane of Chlamydia trachomatis serovar L2.
Hall RT; Strugnell T; Wu X; Devine DV; Stiver HG
Infect Immun; 1993 May; 61(5):1829-34. PubMed ID: 8478073
[TBL] [Abstract][Full Text] [Related]
2. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
Zhang MX; Klein B
Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.
Qu Z; Cheng X; de la Maza LM; Peterson EM
Infect Immun; 1993 Apr; 61(4):1365-70. PubMed ID: 7681045
[TBL] [Abstract][Full Text] [Related]
4. Complement C3 opsonization of Chlamydia trachomatis facilitates uptake in human monocytes.
Lausen M; Christiansen G; Karred N; Winther R; Poulsen TBG; Palarasah Y; Birkelund S
Microbes Infect; 2018; 20(6):328-336. PubMed ID: 29729435
[TBL] [Abstract][Full Text] [Related]
5. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
[TBL] [Abstract][Full Text] [Related]
6. Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants.
Zhang YX; Stewart SJ; Caldwell HD
Infect Immun; 1989 Feb; 57(2):636-8. PubMed ID: 2463971
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivity of the 60 kDa cysteine-rich proteins of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae expressed in Escherichia coli.
Watson MW; Lambden PR; Everson JS; Clarke IN
Microbiology (Reading); 1994 Aug; 140 ( Pt 8)():2003-11. PubMed ID: 7522846
[TBL] [Abstract][Full Text] [Related]
8. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.
Zhang YX; Stewart S; Joseph T; Taylor HR; Caldwell HD
J Immunol; 1987 Jan; 138(2):575-81. PubMed ID: 3540122
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
Nilsson-Ekdahl K; Nilsson B
Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
[TBL] [Abstract][Full Text] [Related]
10. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
Gadd KJ; Reid KB
Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
12. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
14. The low-molecular-mass, cysteine-rich outer membrane protein of Chlamydia trachomatis possesses both biovar- and species-specific epitopes.
Zhang YX; Watkins NG; Stewart S; Caldwell HD
Infect Immun; 1987 Nov; 55(11):2570-3. PubMed ID: 3666953
[TBL] [Abstract][Full Text] [Related]
15. In vitro neutralization of Chlamydia trachomatis by monovalent Fab antibody specific to the major outer membrane protein.
Su H; Caldwell HD
Infect Immun; 1991 Aug; 59(8):2843-5. PubMed ID: 1713202
[TBL] [Abstract][Full Text] [Related]
16. Outer membrane protein binding sites of complement component 3 during opsonization of Haemophilus influenzae.
Hetherington SV; Patrick CC; Hansen EJ
Infect Immun; 1993 Dec; 61(12):5157-63. PubMed ID: 7693595
[TBL] [Abstract][Full Text] [Related]
17. Immunoaccessible peptide sequences of the major outer membrane protein from Chlamydia trachomatis serovar C.
Zhong GM; Brunham RC
Infect Immun; 1990 Oct; 58(10):3438-41. PubMed ID: 1698181
[TBL] [Abstract][Full Text] [Related]
18. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
Takata Y; Tamura N; Fujita T
J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
[TBL] [Abstract][Full Text] [Related]
19. The role of lipopolysaccharide in the exposure of protective antigenic sites on the major outer membrane protein of Chlamydia trachomatis.
Vretou E; Psarrou E; Spiliopoulou D
J Gen Microbiol; 1992 Jun; 138(6):1221-7. PubMed ID: 1382112
[TBL] [Abstract][Full Text] [Related]
20. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.
Kozel TR; Pfrommer GS
Infect Immun; 1986 Apr; 52(1):1-5. PubMed ID: 3514450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
